Implementation of a pre-operative decolonization protocol of Methicillin Resistance Staphylococcus aureus in elective orthopedic surgery at Manatí Medical Center: Pilot Study.
Methicillin-resistant Staphylococcus aureus (MRSA) is a strain of S. aureus that shows resistance to multiple antibiotics. Up to 30% of S. aureus strains isolated from nosocomial infections are MRSA, and it has become a growing problem for public health. The cost of MRSA infection is also having a huge impact financially and results in considerable resource utilization. Puerto Rico’s Legislature passed Law # 298 on October 19, 2012 for the control and prevention of MRSA infections in medical installations in Puerto Rico. In order to comply with the law we conducted a pilot study to identify possible setbacks of the implementation of the MRSA decolonization protocol as standard of care therapy in our institution while contributing to the process of quality improvement and patient safety. Nasal swabs were taken at the Pre-admission Department and processed through a PCR-based MRSA detection assay. A protocol of decolonization in patients with positive results was implemented. The study showed that patients without apparent risk factors could be colonized either with MRSA or Methicillin-sensitive S. aureus (MSSA). The time between pre- admission and surgery was less than the indicated for a proper decolonization procedure. Therefore, 50% of the scheduled surgeries could have been postponed in case of positive MRSA or MSSA. In our experience patient’s education was crucial to guarantee compliance and adherence to treatment. In order to decrease risk of wound infection we recommend that both, screening process and decolonization if required, be performed before the preadmission appointment for elective surgery. This study provided a framework for MRSA pre-admission screening and decolonization in our Institution.
Full text links
Trending Papers
How to improve the efficiency and the safety of real-time ultrasound-guided central venous catheterization in 2023: a narrative review.Annals of Intensive Care 2023 May 26
SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases.International Journal of Molecular Sciences 2023 May 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app